Hereditary breast and ovarian cancer

Research output: Contribution to journalArticle

Abstract

The role of genetics in virtually all forms of gynecologic cancer has received intense interest in both the research and clinical community during the past decade. This interest surged even further in light of the identification of the BRCA1 and BRCA2 genes and their ultimate cloning. Even though there is still a lack of well-designed population-based studies able to define the actual incidence of BRCA-linked BC and OC, the possible identification of women at genetic high risk for BC/OC has represented an essential step toward a decrease in cancer mortality rates. There is a strong variability in penetrance and studies on genetic and environmental factors potentially affecting penetrance are in progress. To date, there is no clear evidence for a significant irfipact of any preventative strategy on cancer risk/mortality in this setting. Nevertheless, counseling on prevention measures is strongly requested by high-risk individuals, whereas data from controlled trials are expected to be available in the next few years. By now, it should be mandatory to treat such individuals at experienced counseling clinics, within IRB-supervised protocols. Increasing is the amount of data about chemoprevention and the inclusion of high-risk subjects in controlled trials should be encouraged. Prophylactic surgery has been shown to decrease cancer risk, but it is less than expected and should only be considered in specific conditions.

Original languageEnglish
Pages (from-to)24-28
Number of pages5
JournalCurrent Problems in Cancer
Volume27
Issue number1
DOIs
Publication statusPublished - Jan 2003

Fingerprint

Ovarian Neoplasms
Breast Neoplasms
Penetrance
Counseling
Neoplasms
BRCA2 Gene
BRCA1 Gene
Mortality
Research Ethics Committees
Chemoprevention
Organism Cloning
Incidence
Research
Population

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Hereditary breast and ovarian cancer. / Greggi, Stefano; Scala, Felice; Laurelli, Giuseppe.

In: Current Problems in Cancer, Vol. 27, No. 1, 01.2003, p. 24-28.

Research output: Contribution to journalArticle

@article{ad427c947f2e45a9bc8fe8241edd174d,
title = "Hereditary breast and ovarian cancer",
abstract = "The role of genetics in virtually all forms of gynecologic cancer has received intense interest in both the research and clinical community during the past decade. This interest surged even further in light of the identification of the BRCA1 and BRCA2 genes and their ultimate cloning. Even though there is still a lack of well-designed population-based studies able to define the actual incidence of BRCA-linked BC and OC, the possible identification of women at genetic high risk for BC/OC has represented an essential step toward a decrease in cancer mortality rates. There is a strong variability in penetrance and studies on genetic and environmental factors potentially affecting penetrance are in progress. To date, there is no clear evidence for a significant irfipact of any preventative strategy on cancer risk/mortality in this setting. Nevertheless, counseling on prevention measures is strongly requested by high-risk individuals, whereas data from controlled trials are expected to be available in the next few years. By now, it should be mandatory to treat such individuals at experienced counseling clinics, within IRB-supervised protocols. Increasing is the amount of data about chemoprevention and the inclusion of high-risk subjects in controlled trials should be encouraged. Prophylactic surgery has been shown to decrease cancer risk, but it is less than expected and should only be considered in specific conditions.",
author = "Stefano Greggi and Felice Scala and Giuseppe Laurelli",
year = "2003",
month = "1",
doi = "10.1067/mcn.2003.120003a",
language = "English",
volume = "27",
pages = "24--28",
journal = "Current Problems in Cancer",
issn = "0147-0272",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Hereditary breast and ovarian cancer

AU - Greggi, Stefano

AU - Scala, Felice

AU - Laurelli, Giuseppe

PY - 2003/1

Y1 - 2003/1

N2 - The role of genetics in virtually all forms of gynecologic cancer has received intense interest in both the research and clinical community during the past decade. This interest surged even further in light of the identification of the BRCA1 and BRCA2 genes and their ultimate cloning. Even though there is still a lack of well-designed population-based studies able to define the actual incidence of BRCA-linked BC and OC, the possible identification of women at genetic high risk for BC/OC has represented an essential step toward a decrease in cancer mortality rates. There is a strong variability in penetrance and studies on genetic and environmental factors potentially affecting penetrance are in progress. To date, there is no clear evidence for a significant irfipact of any preventative strategy on cancer risk/mortality in this setting. Nevertheless, counseling on prevention measures is strongly requested by high-risk individuals, whereas data from controlled trials are expected to be available in the next few years. By now, it should be mandatory to treat such individuals at experienced counseling clinics, within IRB-supervised protocols. Increasing is the amount of data about chemoprevention and the inclusion of high-risk subjects in controlled trials should be encouraged. Prophylactic surgery has been shown to decrease cancer risk, but it is less than expected and should only be considered in specific conditions.

AB - The role of genetics in virtually all forms of gynecologic cancer has received intense interest in both the research and clinical community during the past decade. This interest surged even further in light of the identification of the BRCA1 and BRCA2 genes and their ultimate cloning. Even though there is still a lack of well-designed population-based studies able to define the actual incidence of BRCA-linked BC and OC, the possible identification of women at genetic high risk for BC/OC has represented an essential step toward a decrease in cancer mortality rates. There is a strong variability in penetrance and studies on genetic and environmental factors potentially affecting penetrance are in progress. To date, there is no clear evidence for a significant irfipact of any preventative strategy on cancer risk/mortality in this setting. Nevertheless, counseling on prevention measures is strongly requested by high-risk individuals, whereas data from controlled trials are expected to be available in the next few years. By now, it should be mandatory to treat such individuals at experienced counseling clinics, within IRB-supervised protocols. Increasing is the amount of data about chemoprevention and the inclusion of high-risk subjects in controlled trials should be encouraged. Prophylactic surgery has been shown to decrease cancer risk, but it is less than expected and should only be considered in specific conditions.

UR - http://www.scopus.com/inward/record.url?scp=0037284897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037284897&partnerID=8YFLogxK

U2 - 10.1067/mcn.2003.120003a

DO - 10.1067/mcn.2003.120003a

M3 - Article

C2 - 12569346

AN - SCOPUS:0037284897

VL - 27

SP - 24

EP - 28

JO - Current Problems in Cancer

JF - Current Problems in Cancer

SN - 0147-0272

IS - 1

ER -